MTNB - Matinas BioPharma Holdings Inc (Healthcare: Biotechnology) Projected Earnings Date: 2024-08-12    (Delayed quote data   2025-04-03)
Last
 0.55		 Change
 ⇓ 0.00   (0.00%)		 Volume
  12,338
Open
 0.55		 High
 0.55		 Low
 0.52
8EMA (Daily)
 0.56		 40EMA (Daily)
 0.59		 50EMA (Daily)
 0.63		 STO (Daily)
 43.394		 MACD Hist (Daily)
 0.004
8EMA (Weekly)
 0.581		 40EMA (Weekly)
 2.86		 50EMA (Weekly)
 3.90		 STO (Weekly)
 8.211		 MACD Hist (Weekly)
 0.490
Company Profile
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com